Also from this source

You just read:

EnGeneIC Enters Into Research Collaboration with Takeda to Develop EDV™-Based Immunomodulatory Therapies for Oncology

News provided by

EnGeneIC Ltd.

Oct 09, 2016, 06:11 ET